Assessment of a Vesicular Stomatitis Virus–Based Vaccine by Use of the Mouse Model of Ebola Virus Hemorrhagic Fever-Reference-Cited by-同舟云学术

Assessment of a Vesicular Stomatitis Virus–Based Vaccine by Use of the Mouse Model of Ebola Virus Hemorrhagic Fever

Published:2007-11-15 Issue:s2 Volume:196 Page:S404-S412
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:J INFECT DIS

Author:

Jones Steven M.,Ströher Ute,Fernando Lisa,Qiu Xianggou,Alimonti Judie,Melito Pasquale,Bray Mike,Klenk Hans‐Dieter,Feldmann Heinz

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/196/Supplement_2/S404/18018728/196-Supplement_2-S404.pdf

Reference48 articles.

1. Ebola virus: from discovery to vaccine

2. Centers for Disease Control and Prevention. Bioterrorism agents/diseases. Available at: http://www.bt.cdc.gov/Agent/Agentlist.asp. Accessed 11 October 2007.

3. Hemorrhagic Fever Viruses as Biological Weapons

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infection;Vaccine;2024-01

2. Oral Immunization with rVSV Bivalent Vaccine Elicits Protective Immune Responses, Including ADCC, against Both SARS-CoV-2 and Influenza A Viruses;Vaccines;2023-08-23

3. Oral immunization with rVSV bivalent vaccine elicits protective immune responses, including ADCC, against both SARS-CoV-2 and Influenza A viruses;2023-07-15

4. The potential epidemic threat of Ebola virus and the development of a preventive vaccine;Journal of Biosafety and Biosecurity;2023-06

5. Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases;Signal Transduction and Targeted Therapy;2023-04-07